 |
|
Neuroleptic Malignant Syndrome in Parkinson's Disease After Withdrawal or Alteration of Dopaminergic Therapy
Daniel L. Keyser, MD;
Robert L. Rodnitzky, MD
Arch Intern Med. 1991;151(4):794-796.
Abstract
Neuroleptic malignant syndrome is characterized by altered consciousness, fever, extrapyramidal signs, autonomic instability, elevated creatine kinase level, and leukocytosis. Although originally described in patients receiving neuroleptic drugs, this syndrome may also occur in patients with Parkinson's disease during withdrawal or reduction of levodopa therapy or other dopaminergic drug therapy. We have encountered three cases of neuroleptic malignant syndrome related to withdrawal of levodopa therapy. These cases illustrate the variety of circumstances in which alteration of therapy with dopaminergic drugs can cause this syndrome and the relative unfamiliarity of the neuroleptic malignant syndrome—levodopa relationship among physicians who do not treat large numbers of patients with Parkinson's disease. An understanding of the role of brain dopamine in the pathogenesis of neuroleptic malignant syndrome and an appreciation of the great variety of drugs whose manipulation can result in this potentially fatal syndrome will aid its proper and timely recognition, especially when the offending pharmacologic manipulation does not involve neuroleptic drugs.
(Arch Intern Med. 1991;151:794-796)
Author Affiliations
From the Department of Neurology, University of Iowa College of Medicine, Iowa City.
Footnotes
Accepted for publication June 4, 1990.
Reprint requests to the Department of Neurology, University of Iowa Hospital, Iowa City, IA 52242 (Dr Rodnitzky).
 CiteULike  Connotea  Delicious  Digg  Facebook  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Inpatient Management of Parkinson Disease: Current Challenges and Future Directions
Oguh and Videnovic
The Neurohospitalist 2012;2:28-35.
ABSTRACT
| FULL TEXT
Emergency presentations of Parkinson's disease: early recognition and treatment are crucial for optimum outcome
Ghosh and Liddle
Postgrad. Med. J. 2011;87:125-131.
ABSTRACT
| FULL TEXT
Neuroleptic Malignant Syndrome: A Review for Neurohospitalists
Berman
The Neurohospitalist 2011;1:41-47.
ABSTRACT
| FULL TEXT
Seizures, Stroke, and Other Neurologic Emergencies
Bleck
ACCP Crit Care Med Brd Rev 2009;20:433-466.
FULL TEXT
Do antidepressants have any potential to cause addiction?
Haddad
J Psychopharmacol 1999;13:300-307.
ABSTRACT
The Continuum of Hyperthermic Syndromes With Impaired Dopaminergic Activity
van Hilten and Roos
Arch Intern Med 1992;152:1727-1730.
ABSTRACT
|
